EAP for convalescent plasma no longer enrolling; the FDA authorized emergency use.

See "EAP to EUA transition" box for physician instructions

Learn more

EAP to EUA transition

  • All program forms must be completed and submitted by November 30, 11:59 CST. Any uncompleted work will be submitted to the central IRB as a potential non-compliance.
  • Due to the overwhelming volume of program inquiries, it may take longer to receive a response. We appreciate your patience as we work through our communications backlog.
  • The US COVID Plasma Team is currently focused on collecting missing information and verifying the accuracy of information for each patient enrolled in the EAP.
  • Top priorities

    1. Ensuring information on the patient is accurate
    2. Ensuring physician information is accurate
  • Complete data is vital

    We will improve the accuracy of patient data by:

    • Pursuing delinquent reporting by physicians
    • Obtaining missing medical history information
    • Correcting incorrect data entries (e.g., date of birth)
    • Following up on other missing information, such as when the patient was discharged
  • The US COVID Plasma Data Team contacts site physicians and study coordinators via email and phone to obtain missing data.

Historical EAP program participation

  • Sites
  • Physicians
  • Patients
  • Infused